| Directors: | Dr Charmaine Gittleson (Chair) Dr Gil Price Dr James Garner |
| Auditors: | William Buck Audit (Vic) Pty Ltd Level 20, 181 William Street, Melbourne, Victoria, 3000 |
| Solicitors: | Minter Ellison Collins Arch, 447 Collins Street, Melbourne, Victoria, 3000 |
| Company Secretary: | Ms Deborah Ambrosini |
| Company: | Percheron Therapeutics Limited ACN 095 060 745 |
| Share Register: | Boardroom Pty Limited Level 12, 225 George Street, Sydney, NSW 2000 Telephone: 1300 737 760 International: +61 2 9290 9600 |
| Registered Office: | L30, Collins Place 35 Collins Street Melbourne, VIC 3000 Australia Telephone: +61 3 9827 8999 |
| Australian Stock Exchange: | Percheron Therapeutics Limited shares are quoted on the Australian Stock Exchange. ASX Code: PER |
| Principal Administrative Office & Mailing Address: | L30, Collins Place 35 Collins Street Melbourne, VIC 3000 Australia Telephone: +61 3 9827 8999 Facsimile: +61 3 9859 7701 |
| American Depository Receipts (ADR) Information: | Percheron Therapeutics Limited has established a Level 1 ADR Program. The ADRs trade in the US over-the-counter (OTC) market. Details are as follows: Ratio: 1 ADR = 20 ordinary shares Symbol: ATHJY CUSIP: 037183100 |
| Bankers: | Commonwealth Bank of Australia, Melbourne, Victoria |
| Website: | www.percherontx.com |
